Omeros' (OMER) OMS721 Phase 2 Trial Achieves Key Endpoints
Go back to Omeros' (OMER) OMS721 Phase 2 Trial Achieves Key EndpointsOmeros Corporation (NASDAQ: OMER) | Delayed: 3.04 -0.05 (1.62%) | |||||
---|---|---|---|---|---|---|
Previous Close | $3.09 | 52 Week High | $16.80 | |||
Open | $3.09 | 52 Week Low | $7.20 | |||
Day High | $3.12 | P/E | N/A | |||
Day Low | $3.03 | EPS | $-1.64 | |||
Volume | 245,204 |